![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 50, 39032-39038, December 15, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Max-Planck-Institut für Entwicklungsbiologie,
Abteilung Biochemie, Spemannstrasse 35, 72076 Tübingen, Germany
Received for publication, June 2, 2000, and in revised form, August 16, 2000
Using the known mapping position the gene
encoding a Bacteria are enclosed by an exoskeletal structure found in the
cell envelope (1). In most cases the bag-shaped macromolecule murein
(peptidoglycan) stabilizes the cell mechanically and determines the
shape of the bacterium (2). It is a heteropolymer, made up of glycan
strands composed of an alternating sequence of two amino-sugars
(N-acetylmuramic acid and N-acetylglucosamine)
linked by For Escherichia coli the turnover process has been well
studied, and it could been shown that during one generation up to 50%
of the cell wall gets degraded as a result of normal growth processes
(9, 14). These breakdown products are efficiently reutilized by
E. coli in a recycling process; it could be shown that this
reuse is an important source for the formation of new murein precursors
(15). A major metabolic pathway, describing the fate of the peptide
moiety originating from the breakdown of the murein could be
elucidated. During the early steps of the recycling, the periplasmic
degradation products get taken up by membrane transporters.
Oligopeptides are internalized by the MppA/Opp system (16, 17), whereas
the membrane permease AmpG transports sugar containing muropeptides
(18). In the cytosol the muropeptides get further degraded by the
action of an N-acetylmuramyl-L-alanine amidase
(AmpD; Refs. 19 and 20) and an essential LD-carboxypeptidase (LdcA;
Ref. 21) and
L-alanyl-D-glutamyl-meso-diaminopimelic acid gets released. The tripeptide is recognized by the muropeptide ligase Mpl (22) and added to UDP-N-acetylmuramic acid
(UDP-MurNAc),1 and
UDP-MurNAc-tripeptide, a precursor for murein synthesis, is formed.
The fate of the sugar moiety is not clear despite the fact that the
presence of a Bacterial Strains, Plasmids, and Growth Conditions
The Agar Diffusion Test
LB agar plates (1.5% agar) were overlaid with 3 ml of LB
top-agar (0.7% agar) containing 10 µl of a bacterial culture grown overnight at 37 °C. Filter discs (5 mm diameter) were loaded
with 10 µl of cefoxitin (20 mg/ml), dried, and placed on the agar
plates. After incubation overnight at 37 °C, the diameter of the
inhibition zone was measured.
Determination of the Minimal Inhibitory Concentration of
Cefoxitin
The MIC was determined by plating several hundred cells on LB
agar plates containing a range of concentrations of cefoxitin that
varied by a factor of 2.
To induce DNA Manipulations and PCR
Standard techniques were used for manipulating the plasmid DNA
(26); E. coli was transformed as described by Inoue et
al. (27). Restriction endonucleases were purchased from Roche
Molecular Biochemicals; oligonucleotides came from MWG-Biotech
(Ebersberg, Germany). PCR (28) was performed using PowerScript
polymerase (PAN Systems, Nürnberg, Germany) in a volume of 50 µl of the supplied buffer with 0.5 mM of each primer and
0.1 µg of chromosomal DNA as a template. After initial denaturation
for 3 min at 92 °C, touchdown PCR (29) was performed with 0.5 min of
annealing, 1 min of extension at 72 °C, and 0.5 min of denaturation
at 92 °C. During the PCR, the annealing temperatures were lowered to 61, 59, 57, 55, and 53 °C for three cycles each and finally to 51 °C for another 15 cycles.
Cloning of nagZ and Construction of an Overproducing System
The coding sequence of ycfO was amplified by using
PCR. Both the wt allele (from E. coli AB1157) and
the copy from the glucosaminidase deficient mutant strain E593
were amplified (specific primers 5'-AAAGAATTCGTGGGTCCAGTAATGTTG-3' and
5'-AAAGTCGACCGCTTCCTCACATAAGCC-3') and cloned into the EcoRI
and SalI sites of the vector pBC SK+
(Stratagene, La Jolla, CA). The constructs were termed pBC-nagZ and
pBC-nagZmut, respectively. The addition of an
N-terminal His6 tag to the protein was obtained after
cloning of the PCR product (template chromosomal DNA from E. coli AB1157; primers: 5'-AAAGGATCCATGGGTCCAGTAATGTTGG-3' and 5'-AAAGTCGACCGCTTCCTCACATAAGCC-3') into pQE30 (Qiagen) cut with BamHI and SalI. The resulting plasmid was
named pHN5. All constructs were sequenced; in the case of the mutant
allele several independently obtained clones were subject to sequencing.
Purification of NagZ
To overproduce the His6-tagged NagZ 800 ml of
culture of E. coli XL-1 blue harboring pHN5 were grown in LB
medium with moderate shaking at 37 °C. Expression of the protein was
induced at an A578 of 0.2 by addition of 0.5 mM isopropyl- Purification of Muropeptides
Murein sacculi were isolated as described before and treated
with Assays for Spectrophotometric Assay--
Cell extracts or protein fractions
were incubated at room temperature for 20 min in a volume of 200 µl
containing 0.66 mM PNP- HPLC-based Assay--
To determine the activity on different
muropeptides, a HPLC-based detection system was established. Routinely
50 ng of purified enzyme was incubated for 20 min at room temperature
in 100 µl of buffer (50 mM Hepes, 500 mM
NaCl, pH 7.1) with varying amounts of substrate. After addition of 5 µl of 2% phosphoric acid, the mixture was boiled and centrifuged. 90 µl of the reaction were used for separating the amino-sugars by
rpHPLC on 5-µm Hypersil-ODS (column size, 4.6 × 125 mm;
Bischoff). Chromatography was performed at room temperature at a flow
rate of 1 ml/min using 50 mM sodium phosphate, pH 4.0 using
a methanol gradient (4 to 15%) that was built up in 20 min.
Alternatively, the chromatography conditions as described for the
isolation of muropeptides were employed. Substrate and product peaks
were quantified using calibrated standards (kindly provided by Astrid Ursinus).
Identification and Molecular Cloning of the nagZ Gene--
Mapping
data from Hrebenda (33) and Park (15) suggest a chromosomal location
for the gene of a Sequence Analysis--
The reading frame from the ycfO
gene encodes a protein of a predicted size of 37 kDa. Using the
TopredII algorithm (36), no leader sequence was detected; therefore, a
cytosolic localization is expected. These results are in agreement with
data from Yem and Wu (23), who characterized the cytosolic
Further similarity searches (using the PSI BLAST algorithm; Ref. 37)
performed with the coding sequence of NagZ put the protein to family
III of glycosyl hydrolases, a group of enzymes mainly containing
Characterization of a nagZ Mutant--
Initially, no obvious
phenotype for E593, the mutant isolated by Yem and Wu (23, 24)
was observed. Neither growth rate or cell shape was changed in LB
medium (data not shown). To find out whether NagZ is indeed an enzyme
that is involved in muropeptide recycling, an indirect approach was
chosen. Muropeptides are known effectors of the transcriptional
activator AmpR that controls the expression of AmpC type
To get further insight into the induction process, Purification of His6-NagZ--
To allow a simple
purification of the identified enzyme, the coding region of
nagZ was subcloned into the gene fusion vector pQE30
(Qiagen), and an N-terminal His6 extension was created. The
fusion protein was active in the whole cell glucosaminidase assay (Ref.
23 and data not shown). A high degree of overexpression of the soluble
fusion protein could be obtained upon addition of 0.5 mM
isopropyl- Characterization of NagZ--
An initial characterization of the
enzyme was performed using PNP- Activity of NagZ on Muropeptides--
The role of NagZ in
muropeptide recycling suggests three possible natural substrates. The
major muropeptide released during cell wall turnover by E. coli is the anhydro-disaccharide-tetrapeptide (41). This
disaccharide can be converted to anhydro-disaccharide and to
anhydro-disaccharide-tripeptide by the action of the intracellular amidase AmpD (19) and the LD-carboxypeptidase LdcA (21), respectively. To test activity of NagZ on these muropeptides, they were isolated in a
larger scale. Isolated murein sacculi were degraded to
anhydro-disaccharides by incubation with isolated Slt70 (42);
cross-linked muropeptides were converted to
anhydro-disaccharide-tetrapeptide and anhydro-disaccharide-tripeptide by enzymatic cleavage of the cross-bridge by addition of purified MepA
(11). Disaccharides lacking the peptide side chain were obtained from
isolated sacculi treated with purified
AmiC2 and isolated
Slt70. The muropeptides were isolated by rpHPLC and quantified using
authentic standards (kindly provided by A. Ursinus). An initial
characterization showed that the isolated NagZ accepts all three
muropeptides as substrates (data not shown).
Kinetic Characterization and Inhibition of NagZ--
To find out
about a preference for any of these substrates, a kinetic
characterization of the action of NagZ on the three muropeptides was
performed. The substrate concentration was varied from 1 to 300 µM, and the initial reaction velocity was estimated using
the rpHPLC based assay (Fig.
3A). The apparent kinetic
constants for the different muropeptides were calculated with the
EKI data analysis program that uses a nonlinear regression of
the Michaelis-Menten equation (43). The Km values
determined were 32 µM for
anhydro-disaccharide-tetrapeptide, 29 µM for
anhydro-disaccharide-tripeptide, and 35 µM for
anhydro-disaccharide. These values are nearly identical; it is
concluded that all muropeptides formed during the turnover and
recycling process are substrates for NagZ.
In the assay employed, strong inhibition of enzyme activity was
observed at high substrate concentrations. The graphical presentation of the kinetic data in a Lineweaver-Burk diagram visualizes this effect
(Fig. 3B). The apparent inhibition constant for the
anhydro-disaccharide-tetrapeptide was estimated from a Dixon plot and
found to be approximately 100 µM. Although this value is
higher then the amount of muropeptides found during normal growth
conditions, it is in the range of the intracellular muropeptide
concentration found during
The observation that NagZ activity can be inhibited was further
studied. The influence of different amino-sugars on enzyme activity was
determined. Strong inhibition was found with
N-acetylglucosamine, a product of the glucosaminidase and
with the chromogenic substrate of the enzyme the PNP- By reusing the turnover material, which is released during growth
of the murein sacculus, E. coli saves a substantial amount of energy. Indeed, the recycling process has to be seen as a major energy saving pathway by which precursors for cell wall synthesis are
formed. During exponential growth about 50% of the cell wall gets
released per generation, and about a third of the peptides found in
newly formed precursor molecules originate from recycled material (44).
With the identification of the uptake systems (MppA/Opp and AmpG), the
tripeptide releasing enzymes (AmpD and LdcA) and the muropeptide
ligase Mpl all enzymes needed for the reuse of the peptide are known
(15). In contrast, it is not clear what happens with the disaccharide
moiety taken up by the cell. Although the presence of an intracellular
The muropeptide recycling pathway is not only important for saving
energy, it is used for signaling and sensing processes in Gram-negative
bacteria (47, 48). During growth, turnover material is released in a
controlled manner and gets recycled. Disturbance of this process,
either by mutations in the recycling pathway or by interfering with
cell wall metabolism, leads to changes in the pools of intracellular
molecules formed during their reuse (48, 49). Gram-negative bacteria
are able to detect deviations from normal conditions and thereby sense
the state of the cell wall. Work on the inducible The biochemical characterization of the identified
I thank Joachim-Volker Höltje for
support throughout these studies.
During the review process of this paper
the group of Ted Park published a paper describing the cloning of the
nagZ gene: Cheng, Q., Li, H., Merdek, K., and Park, J. T. (2000) J. Bacteriol. 182, 4836-4840.
*
This work was supported by European Commission Project
BIOU-CT96-0122.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, September 7, 2000, DOI 10.1074/jbc.M004797200
2
M. Templin, manuscript in preparation.
The abbreviations used are:
MurNAc, N-acetylmuramic acid;
anhydro-disaccharide, GlcNAc-
Characterization of a
-N-acetylglucosaminidase of
Escherichia coli and Elucidation of Its Role in
Muropeptide Recycling and
-Lactamase Induction*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1,4-N-acetylglucosaminidase needed for
the degradation of muropeptides could be identified. nagZ
encodes a cytosolic enzyme active on N-actylglucosamyl-
-1,4-(1,6)-anhydromuramic acid
containing muropeptides. These degradation products of the
peptidoglycan are formed during the enlargement of the murein sacculus
as a consequence of a growth mechanism, which couples the controlled
degradation of the cell wall polymer with the insertion of new
material. NagZ is needed for the formation of monosaccharides from the
released disaccharides during the cytosolic steps of the
muropeptide-recycling pathway. The formation of intracellular
1,6-anhydro-N-acetylmuramyl-peptides is important for the
expression control of the inducible
-lactamases of the AmpC type. A
mutant lacking active NagZ cannot establish AmpC mediated
-lactam
resistance. The biochemical characterization of the enzyme showed its
activity on different muropeptides and inhibitors of enzyme activity
could be identified. This observation might be important for designing
inhibitors of NagZ that could prevent the establishment of
-lactam
resistance of Enterobacteria possessing inducible
-lactamases.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1,4 glycosidic bonds (reviewed by Höltje in Ref.
3). The glycans are interlinked by short peptide bridges, and a
covalently closed network completely surrounding the cell is formed. To
enlarge this structure not only does new material have to be
synthesized, it has to be integrated into the existing murein. This is
accomplished by the concerted action of murein synthases and murein
hydrolases (3-6). During the controlled enlargement of the
exoskeleton, old material from the sacculus gets released as turnover
products while the polymer grows by the insertion of new murein glycan strands (7-9). Different enzymatic activities have been
described to take part in this turning over of the murein
sacculus. Lytic transglycosylases are muramidases that are degrading
the glycan strands to anhydro-disaccharides (10), endopeptidases cleave peptide cross-links (11-13) and
N-acetylmuramyl-L-alanine amidases release
oligopeptides from the murein or from muropeptides (7). As a
result of the action of these enzymes, disaccharides
(N-acetylglucosamyl-
-1,4-(1,6)-anhydro-N-acetylmuramic acid) are formed that carry a characteristic 1,6-anhydro ring structure
at the muramic acid.
-1,4-N-acetylglucosaminidase active on muropeptides had been reported over 20 years ago (23, 24). Here the
identification of the gene encoding NagZ, a cytosolic glucosaminidase
involved in muropeptide recycling, is shown. Additionally, its need for
the expression control of certain
-lactamases is described.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1,4-N-acetylglucosaminidase-deficient mutant
E593 (24) is derived from E. coli K-12 AB1157
(F
(gpt-proA62) argE3 his-4 leu-6 thr-1 ara-14
galK2 lacY1 xyl-5 mtl-1 thi-1 supE44 rpsL31 Strr
tsx-33 T6r (
)). The general
cloning host was XL-1 blue (Stratagene, La Jolla, CA). To examine
-lactamase induction, strains were transformed with pJP1 (9), a
plasmid containing the ampR-ampC operon from Enterobacter cloacae (25). pBC SK+ (Stratagene,
La Jolla, CA) was used as cloning vector and pQE30 (Qiagen, Hilden,
Germany) for construction of a His6-tagged NagZ protein.
Bacteria were cultivated aerobically at 37 °C in LB medium. Growth
was monitored by determination of A578 in
an Eppendorf photometer. Transformants were grown in the presence of 40 µg/ml kanamycin, 12.5 µg/ml chloramphenicol, or 50 µg/ml
ampicillin in LB broth or on LB agar plates.
-Lactamase Induction
-lactamase production 20 ml of culture of
exponentially growing bacteria (A578 = 0.4)
carrying pJP1 were diluted with 20 ml of prewarmed medium containing 5 µg/ml cefoxitin. To measure
-lactamase activity, aliquots of the
culture (0.5-4 ml) were removed and cells were harvested by
centrifugation (15,000 × g for 2 min). After washing
with 2 ml of sodium phosphate buffer (50 mM, pH 7.0) cells
were centrifuged again and frozen.
-D-thiogalactopyranoside. After
4 h the cells were harvested by centrifugation, washed with 50 ml
ice-cold buffer A (100 mM sodium phosphate, 100 mM NaCl, pH 7.0), and resuspended in 5 ml buffer A
containing 10 mM imidazol (buffer B). After disrupting the
cells by three passages through a precooled French pressure cell at
15,000 p.s.i. and centrifugation (20 min, 90,000 × g), the supernatant was used for purification of the enzyme
by metal chelation chromatography on Superflow nickel-nitrilotriacetate (Qiagen). After loading of the column (bed volume, 3 ml; equilibrated with buffer B), the column was washed with 60 ml of buffer B at a
flow-rate of 4 ml/h. The protein was eluted with buffer A containing 250 mM imidazol. Glucosaminidase activity in the eluted
fractions was determined by measuring hydrolysis of
PNP-
-GlcNAc, and fractions showing high activity were pooled.
After extensive dialysis against buffer A, the protein was stored at
20 °C.
-amylase and pronase (30). Murein from 20 liters of culture was
completely digested into noncross-linked disaccharide units by
incubation with purified MepA (3 µg) and purified Slt70 (2 µg) in a
volume of 4 ml of buffer (50 mM sodium phosphate, 100 mM NaCl, pH 7.0). Anhydro-disaccharide-tripeptide and
anhydro-disaccharide-tetrapeptide were isolated by rpHPLC (30). To
obtain unsubstituted anhydro-disaccharides isolated sacculi were
degraded with purified Slt70 (2 µg) and isolated AmiC (4 µg). The
anhydro-disaccharides were isolated by rpHPLC on 5-µm Hypersil-ODS
(4.6 mm x 125 mm; Bischoff, Leonberg, Germany). Chromatography was
performed at room temperature at a flow rate of 1 ml/min using 0.1%
trifluoroacetic acid. After 10 min a gradient (0% to 30% acetonitril)
that was built up in 10 min was applied before equilibrating to 0.1%
trifluoroacetic acid for 10 min. Fractions containing muropeptides were
collected and dried.
-1,4-N-acetylglucosaminidase Activity
-GlcNAc, 50 mM Hepes,
pH 7.1, and 500 mM NaCl. The reaction was quenched with 800 µl of 300 mM sodium carbonate, and absorbance measured at
405 nm.
-1,4-N-acetylglucosaminidase activity in whole
cells was measured as described before (24).
-Lactamase Assay--
-Lactamase activity was determined
by measuring hydrolysis of nitrocefin, a chromogenic
-lactam (31).
In contrast to published assay systems, activity was determined in
whole cells, which were permeabilized by treatment with SDS and
chloroform (32). Activity was calculated from
A492/min·amount of cells
(A578). Briefly, 0.1-8 ml of a bacterial
culture (A578 = 0.2-1.2) were centrifuged, and
the cells were resuspended in 750 µl of 50 mM sodium
phosphate buffer, pH 7.0. Cells were permeabilized by the addition of 1 drop of chloroform and one drop of 0.05% SDS solution and vigorous shaking on a vortex mixer for 20 s. 100 µl of different
dilutions of permeabilized cells were mixed with an equal volume of a
Nitrocefin solution (25 µg/ml nitrocefin in 50 mM sodium
phosphate buffer, pH 7.0), and hydrolysis was monitored over 20 min in
a microtiter plate reader at 492 nm. The rate of hydrolysis was
expressed as nM nitrocefin hydrolyzed per 1 A578 of cells/min.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1,4-N-acetylglucosaminidase active on
muropeptides at around 26 min of the E. coli genome. To
identify this gene, the possible reading frames from this region (25 min to 27 min) were subject to data base comparisons using the BLAST
algorithm (34) on the Swiss-Prot data base. One out of the
approximately 100 checked reading frames showed a significant similarity to known glycosyl hydrolases. To show that such an enzyme is
encoded by ycfO (located at 25.1 min, 1163 kilobase pairs of
the physical map of the E. coli genome), the gene was amplified by PCR and subcloned into the cloning vector pBC
SK+. Transformation of E. coli E593, a mutant
deficient in
-1,4-N-acetylglucosaminidase activity, with
this plasmid restored enzyme activity as detected with a whole cell
-N-acetylglucosaminidase assay. Transformation of the
same strain with a plasmid harboring a plasmid with the ycfO
allele from E593 showed no measurable increase in glucosaminidase activity (data not shown). Both alleles were sequenced, and it could be
shown that the wt copy is identical to the published sequence of ycfO (35). For the mutant allele a single base
pair change was detected (changing Gly101 to Asp) and
therefore is responsible for the total loss of activity. The identified
open reading frame was renamed to nagZ as proposed by Park
(15).
-N-acetylglucosaminidase from E. coli AB1157
mapping at 25 min.
-glucosidases. Recently, the active site aspartic acid of ExoII, a
highly similar protein from Vibrio furnissi was identified
(38, 39), and, indeed, this amino acid is conserved in all members of
the family including the newly characterized enzyme. The mutation found
in the nagZ allele from E593 maps close to another conserved
region in the protein (data not shown). Highly similar orthologs were
found within most Enterobacteriaceae sequenced to date, and
searching the unfinished microbial genomes data base (last update, May
16, 2000 at the National Center for Biotechnology Information) revealed
the presence of further homologues (in Salmonella typhi, Salmonella paratyphi, Salmonella
typhimurium, Yersinia pestis, Pasteurella
multocida, Vibrio cholerae, Hemeophilus
influenzae, Hemeophilus ducreyi, Klebsiella
pneumonia, Pseudomonas aeruginosa, Shewanella
putrefaciens, Pseudomonas putida, Salmonella
enteritidis, Neisseria meningitidis, Bordetella
pertussis, Neisseria gonorrhoeae, and Bordetella
bronchiseptica; e values in a tblastn gapped blast search < e
61). This suggests a conserved function
for NagZ.
-lactamases. This activator promotes
-lactamase transcription and
is needed to establish
-lactam resistance. Activation of AmpR only
occurs upon binding of certain muropeptides that are formed during the
cytosolic degradation steps of turnover material from the cell wall.
During normal growth conditions, the intracellular concentration of
these murein metabolites stays low because they are efficiently
recycled. In bacteria treated with
-lactams (e.g.
cefoxitin), a high amount of muropeptides gets released and accumulates
in the cytoplasm. Consequently, AmpR activation is found, and AmpC
production is induced (18). The muropeptides activating AmpR are
anhydro-monosaccharides (anhydro-N-acetyl-muramoyl-peptides) that are products of an N-acetyl-glucosaminidase acting on
the released turnover material. Therefore, a strain carrying a
nagZ mutation was tested for its capability to induce
expression of AmpC type
-lactamases by determination of the
sensitivity against
-lactam antibiotics. E. coli E593 was
transformed with pJP1 (9), a plasmid that carries the
ampR-ampC operon from E. cloacae, and the
influence of the nagZ mutation on the induction process was examined. In an agar diffusion assay the sensitivity to cefoxitin, a
cephalosporin that is a potent inducer of AmpC expression, was determined. In the corresponding control strain (AB1157), the transformation with pJP1 leads to high resistance against
-lactams. In contrast, the mutant E593 harboring the plasmid stayed as sensitive against cefoxitin as a strain not possessing the resistance plasmid (Table I). Introducing a second plasmid
containing the cloned wild type allele of nagZ can
complement this defect; the control transformation with the mutated
nagZ from E593 on a plasmid did not lead to increased
resistance to the cephalosporin. Therefore, it is concluded that the
identified glucosaminidase is involved in muropeptide recycling and is
needed for the establishment of expression of the inducible
-lactamases of the AmpC type.
Sensitivity of a nagZ mutant against cefoxitin
-lactamase
induction was measured in cultures of AB1157 and E593 carrying pJP1
(ampR ampC) after treatment with 2.5 µg/ml cefoxitin.
Activity was determined in culture aliquots (taken every 15 min) in a
newly established whole cell assay (see "Experimental Procedures"). The hydrolysis of nitrocefin, a chromogenic substrate for
-lactamases was monitored, and induction factors could be calculated
for the strains carrying the resistance plasmid (Table
II). For the control a 17-fold induction
(as compared with the untreated control) was found after 45 min, in the
mutant the calculated induction factor was 4.5. Still a substantial
amount of
-lactamase (37.2 nano mol/min × A578) was measured in the induced
nagZ mutant. Although this level of
-lactamase production
does not lead to any increase in
-lactam resistance, it opens the
question how induction can occur in the nagZ mutant. A
possible explanation might be the presence of a second enzyme able to
hydrolyze anhydro-muropeptides. This enzyme could be identical to BglX,
a periplasmic
-D-glucosidase also belonging to the
family III of the glycosyl hydrolases (40). This enzyme, together with
an transporter specific for the released anhydro-monosaccharides would
constitute an unknown way to reutilize turnover material.
-Lactamase induction in a nagZ mutant carrying ampC/ampR from E. cloacae
-Lactamase production was induced by treating growing cells
(A578 = 0.35) with 2.5 µg/ml Cefoxitin.
-Lactamase activity was determined in permeabilized cells by
monitoring the rate of hydrolysis of the chromogenic
-lactam
nitrocefin at 492 nm as described under "Experimental Procedures."
-Lactamase activity is expressed as nano mol/min × A578. The induction factor (in brackets) is the
quotient from induced and uninduced cells.
-D-thiogalactopyranoside (Fig.
1). Metal chelation chromatography was
used for purification on a nickel-nitrilotriacetate-Sepharose column,
and a simple one-step purification procedure was established. Essentially pure protein as judged by SDS-polyacrylamide gel
electrophoresis and Coomassie staining could be obtained (Fig. 1). The
apparent molecular mass (37 kDa) agrees with the calculated value from the predicted amino acid sequence. The protein concentration was found
to be 0.3 mg/ml, and the specific activity on PNP-
-GlcNAc was 8.8 µmol/min mg protein in the standard assay.

View larger version (52K):
[in a new window]
Fig. 1.
Overproduction and purification of
His6-NagZ. Soluble extract of E. coli Xl-1
blue overexpressing His6-NagZ from pHN5 (5 µg of protein,
lane A) and purified His6-NagZ (1 µg of
protein, lane B) were separated in a 10% SDS-polyacrylamide
gel and stained with Coomassie Blue. Molecular size markers are shown
in lane M.
-GlcNAc, a chromogenic substrate for
-1,4-glucosaminidases that had been shown to be accepted by NagZ
(23). In a buffer system containing 50 mM Hepes, the pH
optimum of the enzyme was detected at 7.1, and the temperature optimum
was found at 38 °C. The addition of 1 M NaCl stimulated
the activity 5-fold (Fig. 2). All
experiments described below were therefore performed in 50 mM Hepes buffer, pH 7.1, containing 0.5 M NaCl.
The apparent kinetic constants with PNP-
-GlcNAc as substrate
(calculated from a Lineweaver-Burk diagram) were: Km
310 µM, Vmax 13.3 µmol/min mg
protein at 25 °C.

View larger version (8K):
[in a new window]
Fig. 2.
Biochemical characterization of
His6-NagZ. The pH optimum and the salt dependence of
the purified enzyme were determined using PNP-
-GlcNAc as substrate.
A, the pH optimum was determined in 50 mM Hepes
buffer containing 100 mM NaCl. B, the salt
dependence was determined in 50 mM buffer, pH 7.1. In both
cases 50 ng of purified His6-NagZ were incubated with 0.66 mM PNP-
-GlcNAc as substrate at room temperature for 20 min in a volume of 200 µl. Activity is expressed as µmol PNP formed
per mg enzyme/min.

View larger version (11K):
[in a new window]
Fig. 3.
Substrate specificity of
His6-NagZ. Different amounts of isolated muropeptides
were incubated with 50 ng of purified NagZ under standard conditions.
, anhydro-disaccharide;
, anhydro-disaccharide-tripeptide;
,
anhydro-disaccharide-tetrapeptide. The initial reaction velocity was
calculated from the amount of product formed as quantified by rpHPLC
(A). The Lineweaver-Burk diagram was chosen to visualize the
apparent kinetic constants (B).
-lactamase induction.
-GlcNAc.
MurNAc, GlcNAc-6-phoshate, and chitobiose had no effect on the enzyme.
Interestingly, bulgecin, a glycopeptide that has been shown to inhibit
the soluble lytic transglycosylase Slt70, did inhibit NagZ activity
(Table III). In vivo,
inhibitors of NagZ need to be present in the cytosol, and uptake
systems internalizing such compounds are needed. Because the identified
inhibitors are all different amino-sugars, it seems possible that known
sugar transporters will faciliate the uptake of such compounds.
Inhibition of NagZ activity by different amino sugars
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1,4-N-acetylglucosaminidase active on muropeptides has
been described (23), its physiological function has not been clarified.
This work could show that this enzyme leads to the formation of
cytosolic monosaccharides. For one of the reaction products of NagZ,
N-acetylglucosamine, a reutilization by feeding it into the
described metabolic pathways using this amino-sugar seems likely.
Still, a cytosolic sugar kinase converting this amino-sugar into
N-acetylglucosamine-phosphate has to be identified. The
other product, 1,6-anhydro-muramic acid substituted with a side peptide
at the lactyl moiety is subject to further enzymatic degradation. The
action of the cytosolic
N-acetylmuramyl-L-alanine amidase AmpD leads to
the release of the anhydro-muramic acid. This is an unusual sugar
containing an intramolecular ring from C-1 to C-6 formed during the
enzymatic cleavage of the
-1,4-glycosidic bond between the
N-acetylmuramic acid and the N-acetylglucosamine by the action of the lytic transglycosylases. These muramidases catalyze the cleavage of the glycosidic bond found in the glycan strands of the polymer during the turnover of the murein sacculus. The
cleavage occurs not by hydrolysis but by an intramolecular transglycosylation reaction (10, 45). Part of the energy released during splitting of the bond gets used to create the intramolecular 1,6-ring, and anhydro-muropeptides are formed. It has been argued that
this is a way of saving energy that can be used during the metabolism
of the anhydro-sugars (46). Therefore the reuse of 1,6-anhydro-muramic
acid might be accomplished by a way different from known sugar
utilizing systems. A phosphorylation mechanism taking advantage of the
energy stored in the intramolecular ring might be involved in
metabolizing these sugars. Even a direct conversion into an UDP
activated muramic acid, an early precursor for cell wall synthesis,
might be envisioned.
-lactamases of the
AmpC type has shown how pools of intracellular metabolites from
degradation and synthesis of the murein are used for signaling. Changes
in the amount of the anhydro-N-acetylmuramyl-peptides (tri-,
tetra-, or pentapeptides) lead to differences in the expression pattern of the AmpC
-lactamases (41). The sensing device coupling the muropeptide recycling pathway to precursor synthesis is the
transcriptional activator AmpR. It has the ability to complex
UDP-MurNAc-pentapeptide and stays inactive upon binding. In the
presence of high amounts of the
anhydro-N-acetylmuramyl-peptides, this murein precursor gets
displaced, and AmpR gets functional as transcriptional activator (48).
Therefore, by measuring the relative amounts of precursors and
degradation products, information about the state of the cell wall can
be obtained. In the case of the inducible
-lactamase, the increased
degradation of the murein caused by the presence of
-lactams is
detected and leads to expression induction of AmpC. Actually most of
the proteins needed for recycling have been identified during studies
of the expression control of
-lactamases, and only later could their
primary function be elucidated (15). Here an opposing approach was
chosen. By identifying and characterizing an enzyme needed for
muropeptide recycling, information about its role in the establishment
of
-lactam resistance was obtained. The need of a
-1,4-N-acetylglucosaminidase for the formation of the
positive effectors (anhydro-N-acetylmuramyl-peptides) of AmpR is obvious because they are formed as reaction products of this
enzymatic activity. Consequently, a mutant lacking NagZ is not able to
produce the activating monosaccharides. This work could show that the
enzyme is indeed needed for establishing the resistant state. The
sensitivity against
-lactams that is found for a nagZ
mutant transformed with a plasmid carrying the ampRC operon
is comparable with a situation where no ampC gene is
present. Therefore, the inactivation of this glucosaminidase can be
seen as a possibility to inhibit expression of inducible
-lactamases and lock bacteria capable of producing AmpC in a sensitive state.
-1,4-N-acetylglucosaminidase NagZ demonstrated some
properties of the enzyme that are of interest in this context. The
possibility to inhibit enzyme activity by addition of various
amino-sugars might allow the design of specific inhibitors of NagZ.
Such compounds would act as indirect effectors on AmpC expression and
prevent expression induction of AmpC type
-lactamases. These enzymes are important virulence factors in a variety of pathogenic
Gram-negative microorganisms, and novel approaches to treat infections
caused by these bacteria are needed. By using inhibitors of NagZ,
production of
-lactamases could be prevented, and strains resistant
against
-lactam antibiotics could be rendered sensitive again.
![]()
ACKNOWLEDGEMENT
![]()
Note Added in Proof
![]()
FOOTNOTES
To whom correspondence should be addressed. Present address: NMI,
an der Universität Tübingen, Markwiesenstr. 55, 72770 Reutlingen, Germany. Tel.: 49-7121-51530-802; Fax: 49-7121-51530-16; E-mail: Templin@nmi.de.
![]()
ABBREVIATIONS
-1,4-(1,6)-anhydro-MurNAc;
PNP, p-nitrophenol;
rpHPLC, reversed phase high pressure liquid chromatography;
PCR, polymerase chain reaction.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Weidel, W.,
and Pelzer, H.
(1964)
Adv. Enzymol.
26,
193-232
2.
Park, J. T.
(1996)
in
Escherichia coli and Salmonella
(Neidhardt, F. C., ed), Vol. 1
, pp. 48-57, ASM Press, Washington, D.C.
3.
Höltje, J. V.
(1998)
Microbiol. Mol. Biol. Rev.
62,
181-203
4.
Höltje, J. V.
(1996)
Microbiology
142,
1911-1918
5.
Vollmer, W.,
von Rechenberg, M.,
and Höltje, J. V.
(1999)
J. Biol. Chem.
274,
6726-6734
6.
Romeis, T.,
and Höltje, J. V.
(1994)
J. Biol. Chem.
269,
21603-21607
7.
Goodell, E. W.,
and Schwarz, U.
(1985)
J. Bacteriol.
162,
391-397
8.
Goodell, E. W.
(1985)
J. Bacteriol.
163,
305-310
9.
Kraft, A. R.,
Prabhu, J.,
Ursinus, A.,
and Höltje, J. V.
(1999)
J. Bacteriol.
181,
7192-7198
10.
Höltje, J.-V.,
Mirelman, D.,
Sharon, N.,
and Schwarz, U.
(1975)
J. Bacteriol.
124,
1067-1076
11.
Keck, W.,
van Leeuwen, A. M.,
Huber, M.,
and Goodell, E. W.
(1990)
Mol. Microbiol.
4,
209-219
12.
Korat, B.,
Mottl, H.,
and Keck, W.
(1991)
Mol. Microbiol.
5,
675-684
13.
Romeis, T.,
and Höltje, J. V.
(1994)
Eur. J. Biochem.
224,
597-604
14.
Park, J. T.
(1993)
J. Bacteriol.
175,
7-11
15.
Park, J. T.
(1996)
Microb. Drug Resist.
2,
105-112
16.
Goodell, E. W.,
and Higgins, C. F.
(1987)
J. Bacteriol.
169,
3861-3865
17.
Park, J. T.,
Raychaudhuri, D.,
Li, H.,
Normark, S.,
and Mengin-Lecreulx, D.
(1998)
J. Bacteriol.
180,
1215-1223
18.
Jacobs, C.,
Huang, L. J.,
Bartowsky, E.,
Normark, S.,
and Park, J. T.
(1994)
EMBO J.
13,
4684-4694
19.
Höltje, J. V.,
Kopp, U.,
Ursinus, A.,
and Wiedemann, B.
(1994)
FEMS Microbiol. Lett.
122,
159-164
20.
Jacobs, C.,
Joris, B.,
Jamin, M.,
Klarsov, K.,
Van Beeumen, J.,
Mengin-Lecreulx, D.,
van Heijenoort, J.,
Park, J. T.,
Normark, S.,
and Frere, J. M.
(1995)
Mol. Microbiol.
15,
553-559
21.
Templin, M. F.,
Ursinus, A.,
and Höltje, J. V.
(1999)
EMBO J.
18,
4108-4117
22.
Mengin-Lecreulx, D.,
van Heijenoort, J.,
and Park, J. T.
(1996)
J. Bacteriol.
178,
5347-5352
23.
Yem, D. W.,
and Wu, H. C.
(1976)
J. Bacteriol.
125,
324-331
24.
Yem, D. W.,
and Wu, H. C.
(1976)
J. Bacteriol.
125,
372-373
25.
Kopp, U.,
Wiedemann, B.,
Lindquist, S.,
and Normark, S.
(1993)
Antimicrob. Agents Chemother.
37,
224-228
26.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
27.
Inoue, H.,
Nojima, H.,
and Okayama, H.
(1990)
Gene (Amst.)
96,
23-28
28.
Saiki, R. K.,
Gelfand, D. H.,
Stoffel, S.,
Scharf, S. J.,
Higuchi, R.,
Horn, G. T.,
Mullis, K. B.,
and Erlich, H. A.
(1988)
Science
239,
487-491
29.
Don, R. H.,
Cox, P. T.,
Wainwright, B. J.,
Baker, K.,
and Mattik, J. S.
(1991)
Nucleic Acids Res.
19,
4008
30.
Glauner, B.
(1988)
Anal. Biochem.
172,
451-464
31.
O'Callaghan, C. H.,
Morris, A.,
Kirby, S. M.,
and Shingler, A. H.
(1972)
Antimicrob. Agents Chemother.
1,
283-288
32.
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
33.
Hrebenda, J.
(1979)
Acta Microbiol. Pol.
28,
53-62
34.
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
35.
Blattner, F. R.,
Plunkett, G., 3rd,
Bloch, C. A.,
Perna, N. T.,
Burland, V.,
Riley, M.,
Collado-Vides, J.,
Glasner, J. D.,
Rode, C. K.,
Mayhew, G. F.,
Gregor, J.,
Davis, N. W.,
Kirkpatrick, H. A.,
Goeden, M. A.,
Rose, D. J.,
Mau, B.,
and Shao, Y.
(1997)
Science
277,
1453-1474
36.
Claros, M. G.,
and von Heijne, G.
(1994)
Comput. Appl. Biosci.
10,
685-686
37.
Altschul, S. F.,
and Koonin, E. V.
(1998)
Trends Biochem. Sci.
23,
444-447
38.
Vocadlo, D. J.,
Mayer, C.,
He, S.,
and Withers, S. G.
(2000)
Biochemistry
39,
117-126
39.
Chitlaru, E.,
and Roseman, S.
(1996)
J. Biol. Chem.
271,
33433-33439
40.
Yang, M.,
Luoh, S. M.,
Goddard, A.,
Reilly, D.,
Henzel, W.,
and Bass, S.
(1996)
Microbiology
142,
1659-1665
41.
Wiedemann, B.,
Dietz, H.,
and Pfeifle, D.
(1998)
Clin. Infect. Dis.
27 (Suppl. 1),
42-47
42.
Templin, M. F.,
Edwards, D. H.,
and Höltje, J. V.
(1992)
J. Biol. Chem.
267,
20039-20043
43.
Bisswanger, H.
(1994)
Enzymkinetik
, Verlag Chemie, Weinheim, Germany
44.
Park, J. T.
(1995)
Mol. Microbiol.
17,
421-426
45.
Thunnissen, A. M.,
Isaacs, N. W.,
and Dijkstra, B. W.
(1995)
Proteins
22,
245-258
46.
Höltje, J. V.
(1995)
Arch. Microbiol.
164,
243-254
47.
Jacobs, C.
(1997)
Science
278,
1731-1732
48.
Jacobs, C.,
Frere, J.-M.,
and Normark, S.
(1997)
Cell
88,
823-832
49.
Kohlrausch, U.,
and Höltje, J. V.
(1991)
J. Bacteriol.
173,
3425-3431
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. T. Park and T. Uehara How Bacteria Consume Their Own Exoskeletons (Turnover and Recycling of Cell Wall Peptidoglycan) Microbiol. Mol. Biol. Rev., June 1, 2008; 72(2): 211 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uehara and J. T. Park Growth of Escherichia coli: Significance of Peptidoglycan Degradation during Elongation and Septation J. Bacteriol., June 1, 2008; 190(11): 3914 - 3922. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Garcia and J. P. Dillard Mutations in ampG or ampD Affect Peptidoglycan Fragment Release from Neisseria gonorrhoeae J. Bacteriol., June 1, 2008; 190(11): 3799 - 3807. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Lynch, L. Dixon, M. R. Benoit, E. L. Brodie, M. Keyhan, P. Hu, D. F. Ackerley, G. L. Andersen, and A. Matin Role of the rapA Gene in Controlling Antibiotic Resistance of Escherichia coli Biofilms Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3650 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uehara and J. T. Park An Anhydro-N-Acetylmuramyl-L-Alanine Amidase with Broad Specificity Tethered to the Outer Membrane of Escherichia coli J. Bacteriol., August 1, 2007; 189(15): 5634 - 5641. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Stubbs, M. Balcewich, B. L. Mark, and D. J. Vocadlo Small Molecule Inhibitors of a Glycoside Hydrolase Attenuate Inducible AmpC-mediated beta-Lactam Resistance J. Biol. Chem., July 20, 2007; 282(29): 21382 - 21391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herve, A. Boniface, S. Gobec, D. Blanot, and D. Mengin-Lecreulx Biochemical Characterization and Physiological Properties of Escherichia coli UDP-N-Acetylmuramate:L-Alanyl-{gamma}-D-Glutamyl-meso- Diaminopimelate Ligase J. Bacteriol., June 1, 2007; 189(11): 3987 - 3995. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uehara, K. Suefuji, T. Jaeger, C. Mayer, and J. T. Park MurQ Etherase Is Required by Escherichia coli in Order To Metabolize Anhydro-N-Acetylmuramic Acid Obtained either from the Environment or from Its Own Cell Wall J. Bacteriol., February 15, 2006; 188(4): 1660 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uehara, K. Suefuji, N. Valbuena, B. Meehan, M. Donegan, and J. T. Park Recycling of the Anhydro-N-Acetylmuramic Acid Derived from Cell Wall Murein Involves a Two-Step Conversion to N-Acetylglucosamine-Phosphate J. Bacteriol., June 1, 2005; 187(11): 3643 - 3649. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mengin-Lecreulx and B. Lemaitre Structure and metabolism of peptidoglycan and molecular requirements allowing its detection by the Drosophila innate immune system Innate Immunity, April 1, 2005; 11(2): 105 - 111. [Abstract] [PDF] |
||||
![]() |
T. Uehara and J. T. Park The N-Acetyl-D-Glucosamine Kinase of Escherichia coli and Its Role in Murein Recycling J. Bacteriol., November 1, 2004; 186(21): 7273 - 7279. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Dahl, T. Jaeger, B. T. Nguyen, J. M. Sattler, and C. Mayer Identification of a Phosphotransferase System of Escherichia coli Required for Growth on N-Acetylmuramic Acid J. Bacteriol., April 15, 2004; 186(8): 2385 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
|